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Abstract
Background: Eosinophilic esophagitis (EoE) is an increasingly diagnosed disease, especially in the western world.
Although its pathogenesis remains poorly understood, there is strong evidence that the eosinophilic inflammation
in EoE is primarily triggered by immune dysregulation secondary to allergic sensitization to dietary or aero-
allergens. Recent studies have reported a higher prevalence of EoE in children with congenital gastrointestinal
malformations, i.e. esophageal atresia and/or tracheoesophageal fistula.
Case presentation: We present the case history of a 2-year-old boy who developed EoE in the aftermath of
congenital diaphragmatic hernia (CDH) repair.
Conclusions: To the best of our knowledge, the following case report describes for the first time the possible
association between CDH and EoE. Given the increasing reported prevalence of EoE in children with congenital
gastrointestinal malformations, EoE should be rule out also in CDH survivors.
Background
Eosinophilic esophagitis (EoE) is an increasingly
diagnosed disease in both pediatric and adult patients,
especially in the western world [1]. EoE is currently de-
fined as a chronic, immune/antigen-mediated esophageal
disease characterized clinically by symptoms related to
esophageal dysfunction and histologically by eosinophil-
predominant inflammation [2]. Although the pathogen-
esis remains poorly understood, there is strong evidence
that the eosinophilic inflammation in EoE is primarily
triggered by immune dysregulation secondary to allergic
sensitization to dietary or aero-allergens [3]. While
adolescents and adults are more likely to suffer from
dysphagia and episodes of food impaction, in children
EoE may present with a wide variety of nonspecific,
gastroesophageal reflux disease (GERD)-like symptoms,
including feeding difficulty, nausea and vomiting, heart-
burn, and failure to thrive, and the index of suspicion for
EoE should be raised in all patients in whom antireflux
medication is unsuccessful in resolving symptoms [4].
Recent studies have reported a higher prevalence
of EoE in children with congenital gastrointestinal
malformations, i.e. esophageal atresia and/or tracheoeso-
phageal fistula [5–7].
We present the case history of a patient who
developed EoE in the aftermath of congenital diaphrag-
matic hernia (CDH) repair.
Case presentation
A 2-year-old boy presented to our unit for recurrent
vomiting associated with persistent cough.
His history was characterized by prenatal diagnosis of
left CDH. He was born through an elective cesarean
section at 37 weeks of gestation and immediately intu-
bated and assisted with high-frequency ventilation. At
2 days of life, the surgical repair of CDH was performed.
The procedure was executed without any complications
and the patient recovered in neonatal intensive care unit
for the first two months of life. However, at 1 month of
life, for the detection of failure to thrive associated with
vomiting and feeding difficulties, GERD, a well-recognized
consequence of CDH, was diagnosed and an antireflux
therapy (omeprazole, 10 mg daily) was started with initial
improvement in symptoms.
When we evaluated the patient at 2 years of age, the
persistence of esophageal symptoms unresponsive to
prolonged antireflux therapy represented an indication
for esophagogastroduodenoscopy. Endoscopy revealed
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only mucosal erythema in the lower half of the esopha-
gus. Moreover, esophageal biopsy specimens taken from
different parts of the esophagus showed a mean eosino-
phil count of 40 eosinophils per high-power field [HPF],
allowing the final diagnosis of EoE. Complementary
testing revealed an elevated serum immunoglobulin E
level and positive skin-prick tests for egg, milk and fish.
With the introduction of the targeted elimination diet
and swallowed inhaled fluticasone (200 mcg daily), we
observed symptoms resolution and both endoscopic and
histologic remission.
Discussion
To the best of our knowledge, this is the first literature
report of EoE as a follow-up complication of CDH.
The outcome of newborns with CDH has improved
rapidly with recent advances in perinatal intensive care,
resulting in an increasing survival [8]; however, in
follow-up studies of infants born with CDH, many
complications including gastrointestinal problems have
been described [8]. In particular, GERD is reported in
up to 62 % of CDH survivors [9]. Many factors may
contribute to the pathogenesis of GERD after CDH
repair. The combination of increased abdominal-
intrathoracic pressure gradient, resulting from position-
ing the hernial contents into the abdominal cavity
during the repairing procedures, and the underdeve-
lopment of the diaphragmatic crus may increase the
strain on the crus facilitating the passage of gastric
contents to the esophagus [10]. Moreover, abnormality
of the esophageal dimensions might also contribute to
development of gastroesophageal reflux [10]. Finally,
there is evidence of abnormal enteric innervation in
CDH and it is likely that esophago-gastric peristalsis
is abnormal [10]. The clinical presentation of CDH-
associated GERD may vary, including recurrent vomiting
and regurgitation, recurrent episodes of bradycardia and
respiratory arrest, failure to thrive and recurrent pneumo-
nia [11]. In adult CDH survivors, incidence of esophagitis
complicating GERD is 54 %, which is significantly higher
than the expected 2 % of endoscopic assessed esophagitis
in the general adult population [12]. Considering these
data, a long-term follow-up for GERD, including endo-
scopic evaluation, is mandatory in CDH survivors.
The association between GERD and EoE has been long
investigated. The exact interplay between these diseases
remains unclear. However, possible explanations for
the interaction between EoE and GERD include three
major mechanisms. The first hypothesis speculates that
both diseases coexist but unrelated: GERD has a high
incidence in general population, affecting approximately
20 % of adult in western countries, so unrelated coexist-
ence is very likely. Regarding the second pathogenetic
mechanism, it has been demonstrated that EoE induces
esophageal remodeling with tissue fibrosis that might
affect lower esophageal sphincter, favoring GERD.
Moreover, eosinophils produce several substances that
alter esophageal motility, causing delayed esophageal
clearance of refluxed material and increasing contact
time with refluxed gastric juice, thus promoting the
development of GERD. Finally, as third hypothesis, it is
possible that GERD contributes to or causes EoE by
inducing epithelial changes that predispose to EoE. It
has been demonstrated that the normally impermeable
esophageal mucosa, when exposed to acid, becomes
permeable for peptides up to 20 kDa. Therefore, the
deeper esophageal layers may become exposed to aller-
gens that might cause EoE. In addition, GERD may
contribute to esophageal eosinophilia by inducing the
expression of eosinophil chemoattractants [13].
The diagnosis of EoE is defined by multiple criteria:
symptoms related to esophageal dysfunction; histologic
evidence of eosinophilia limited to the esophagus (and
not in other parts of the gastrointestinal tract), where
finding 15 esophageal intraepithelial eosinophils per
HPF is accepted as the minimum threshold for diagno-
sis; the disease should remit with treatments of dietary
exclusion, topical corticosteroids, or both; the esopha-
geal eosinophilia should not be responsive to proton
pump inhibitor (PPI) therapy alone [2].
Because the presenting symptoms are similar, many
patients are initially thought to have GERD. The main
histologic characteristic of EoE is the presence of eosino-
phils in the esophageal mucosa and submucosa, whereas
eosinophils virtually are absent in the normal esophagus.
Eosinophils may also be present in other conditions,
especially reflux esophagitis. Although the esophageal
eosinophil count in patients with GERD seldom sur-
passes 7 eosinophils/HPF, in EoE they reach far higher
concentrations; in the proper clinical context, a peak
count of more than 15 intraepithelial eosinophils/HPF is
required for the diagnosis of EoE. For a definite differen-
tiation from reflux esophagitis, it is suggested that symp-
toms and histology do not improve on adequate
antireflux treatment, preferably with PPIs [2].
In our report, a 2-year-old boy developed EoE as a
follow-up complication of CDH repair. The case meets
the definition for EoE because the number of intrae-
pithelial eosinophils was considerably higher than 15
and because antireflux treatment was unsuccessful. As
previously theorized for other congenital gastrointestinal
malformations, i.e. esophageal atresia and tracheoeso-
phageal fistula, we speculate that, in CDH patients,
GERD, a well-recognized consequence of CDH, could
predispose to EoE by altering the esophageal mucosal
permeability to allergens and by inducing the expression
of eosinophil chemoattractants. Furthermore, after CDH
repair, esophageal motility disturbances may prolong the
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exposure to potential allergens for the already-damaged
mucosa, increasing the risk of local sensitization to
potential antigens.
These observations suggest the possibility of consider-
ing EoE in CDH survivors with GERD-like symptoms
and dysphagia refractory to antireflux medications.
The differential diagnosis between GERD and EoE is
fundamental in order to set up a targeted therapy. In
particular, EoE will not respond to antireflux therapy but
only to dietary exclusion, topical corticosteroids, or both;
finally anedoctal cases have reported the efficacy of
omalizumab in the treatment of EoE [14].
Conclusion
Given the increasing reported prevalence of EoE in
children with congenital gastrointestinal malformations,
EoE should be rule out also in CDH survivors before
considering antireflux surgery for GERD refractory to
drugs.
Abbreviations
CDH: Congenital diaphragmatic hernia; EoE: Eosinophilic esophagitis;





The authors declare that they have no sources of funding.
Availability of data and materials
All clinical data concerning the manuscript are available in case of Editorial
request.
Authors’ contributions
AL and RC assisted with the draft of the initial manuscript, reviewed the
literature and prepared the final manuscript as submitted. GLM critically
reviewed the manuscript, and approved the final manuscript as submitted.
All authors approved the final manuscript as submitted and agree to be
accountable for all aspects of the work.
Competing interests
The authors declare no conflicts of interest. No honorarium, grant, or other
form of payment was given to anyone to produce the manuscript.
Ethics approval and consent to participate
Written informed consent was obtained from the patient’s parents for
publication of this Case report and any accompanying images. A copy of the
written consent is available for review by the Editor-in-Chief of this journal.
Received: 1 September 2016 Accepted: 2 November 2016
References
1. Dellon ES. Epidemiology of eosinophilic esophagitis. Gastroenterol Clin
North Am. 2014;43(2):201–18.
2. Papadopoulou A, Koletzko S, Heuschkel R, Dias JA, Allen KJ, Murch SH, et al.
Management guidelines of eosinophilic esophagitis in childhood. J Pediatr
Gastroenterol Nutr. 2014;58(1):107–18.
3. Sherrill JD, Rothenberg ME. Genetic and epigenetic underpinnings of
eosinophilic esophagitis. Gastroenterol Clin North Am. 2014;43(2):269–80.
4. Furuta GT, Katzka DA. Eosinophilic Esophagitis. N Engl J Med. 2015;373(17):1640–8.
5. Krishnan U. Eosinophilic Esophagitis in Children with Esophageal Atresia. Eur
J Pediatr Surg. 2015;25(4):336–44.
6. Oliveira C, Zamakhshary M, Marcon P, Kim PC. Eosinophilic esophagitis and
intermediate esophagitis after tracheoesophageal fistula repair: a case series.
J Pediatr Surg. 2008;43(5):810–4.
7. Gorter RR, Heij HA, van der Voorn JP, Kneepkens CM. Eosinophilic
esophagitis after esophageal atresia: is there an association? Case
presentation and literature review. J Pediatr Surg. 2012;47(6):e9–e13.
8. Morini F, Lally PA, Lally KP, Bagolan P. The Congenital Diaphragmatic Hernia
Study Group Registry. Eur J Pediatr Surg. 2015;25(6):488–96.
9. Kawahara H, Okuyama H, Nose K, Yoneda A, Kubota A, Fukuzawa M.
Physiological and clinical characteristics of gastroesophageal reflux after
congenital diaphragmatic hernia repair. J Pediatr Surg. 2010;45(12):2346–50.
10. Tovar JA. Congenital diaphragmatic hernia. Orphanet J Rare Dis. 2012;7:1.
11. Molina-Infante J, van Rhijn BD. Interactions between gastro-oesophageal
reflux disease and eosinophilic oesophagitis. Best Pract Res Clin
Gastroenterol. 2015;29(5):749–58.
12. Peetsold MG, Kneepkens CM, Heij HA, Gemke RJ. Congenital diaphragmatic
hernia: long-term risk of gastroesophageal reflux disease. J Pediatr
Gastroenterol Nutr. 2010;51(4):448–53.
13. Cheng E, Souza RF, Spechler SJ. Eosinophilic esophagitis: interactions with
gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014;43(2):243–56.
14. Licari A, Marseglia A, Caimmi S, Castagnoli R, Foiadelli T, Barberi S, et al.
Omalizumab in children. Paediatr Drugs. 2014;16(6):491–502.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Licari et al. Italian Journal of Pediatrics  (2016) 42:96 Page 3 of 3
